TNF and psoriatic arthritis: Infliximab is a chimeric monoclonal anti-TNF antibody used to treat several inflammatory diseases, namely, the spondyloarthropathies (ankylosing spondylitis and psoriatic arthritis), rheumatoid arthritis, and inflammatory bowel disease [12, 13, 21].